CEMTREX INC (CETX)

US15130G7097 - Common Stock

0.3  -0.01 (-1.8%)

After market: 0.2936 -0.01 (-2.13%)

Fundamental Rating

2

Overall CETX gets a fundamental rating of 2 out of 10. We evaluated CETX against 127 industry peers in the Electronic Equipment, Instruments & Components industry. CETX has a bad profitability rating. Also its financial health evaluation is rather negative. CETX is not valued too expensively and it also shows a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year CETX has reported negative net income.
In the past year CETX has reported a negative cash flow from operations.
In the past 5 years CETX always reported negative net income.
In the past 5 years CETX reported 4 times negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -9.82%, CETX is not doing good in the industry: 68.25% of the companies in the same industry are doing better.
With a Return On Equity value of -65.85%, CETX is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -9.82%
ROE -65.85%
ROIC N/A
ROA(3y)-20.93%
ROA(5y)-26.96%
ROE(3y)-83.87%
ROE(5y)-80.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 43.14%, CETX is in the better half of the industry, outperforming 76.98% of the companies in the same industry.
CETX's Gross Margin has improved in the last couple of years.
CETX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.26%
GM growth 5Y3.58%

0

2. Health

2.1 Basic Checks

CETX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CETX has more shares outstanding
The number of shares outstanding for CETX has been increased compared to 5 years ago.
The debt/assets ratio for CETX is higher compared to a year ago.

2.2 Solvency

CETX has an Altman-Z score of -0.68. This is a bad value and indicates that CETX is not financially healthy and even has some risk of bankruptcy.
CETX has a worse Altman-Z score (-0.68) than 75.40% of its industry peers.
CETX has a Debt/Equity ratio of 1.00. This is a high value indicating a heavy dependency on external financing.
CETX has a worse Debt to Equity ratio (1.00) than 86.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z -0.68
ROIC/WACCN/A
WACC2.32%

2.3 Liquidity

A Current Ratio of 0.92 indicates that CETX may have some problems paying its short term obligations.
CETX's Current ratio of 0.92 is on the low side compared to the rest of the industry. CETX is outperformed by 91.27% of its industry peers.
A Quick Ratio of 0.64 indicates that CETX may have some problems paying its short term obligations.
CETX's Quick ratio of 0.64 is on the low side compared to the rest of the industry. CETX is outperformed by 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.64

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.94% over the past year.
The Revenue has grown by 30.98% in the past year. This is a very strong growth!
The Revenue has been growing by 21.31% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)76.94%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q71.18%
Revenue 1Y (TTM)30.98%
Revenue growth 3Y10.92%
Revenue growth 5Y21.31%
Revenue growth Q2Q41%

3.2 Future

CETX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.92% yearly.
Based on estimates for the next years, CETX will show a quite strong growth in Revenue. The Revenue will grow by 16.02% on average per year.
EPS Next Y81.31%
EPS Next 2Y44.26%
EPS Next 3Y31.92%
EPS Next 5YN/A
Revenue Next Year18.09%
Revenue Next 2Y16.53%
Revenue Next 3Y16.02%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 0.53, which indicates a rather cheap valuation of CETX.
CETX's Price/Forward Earnings ratio is rather cheap when compared to the industry. CETX is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.72, CETX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.53

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CETX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 41.8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CETX's earnings are expected to grow with 31.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.26%
EPS Next 3Y31.92%

0

5. Dividend

5.1 Amount

CETX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CEMTREX INC

NASDAQ:CETX (5/2/2024, 6:04:37 PM)

After market: 0.2936 -0.01 (-2.13%)

0.3

-0.01 (-1.8%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap318.00K
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.53
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.82%
ROE -65.85%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 43.14%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.92
Quick Ratio 0.64
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)76.94%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y81.31%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)30.98%
Revenue growth 3Y10.92%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y